S&P 500
$5,892.58
+0.1%
+$6.03
DJI
$42,051.06
-0.2%
-$89.37
NASDAQ
$19,146.81
+0.7%
+$136.72
Bitcoin
$103,810.00
-0.1%
-$107.81
AAPL
$212.34
-0.3%
-$0.59
AMZN
$210.09
-0.6%
-$1.28
GOOG
$166.80
+3.7%
+$5.91
META
$659.47
+0.5%
+$3.44
MSFT
$452.80
+0.8%
+$3.66
NVDA
$135.29
+4.1%
+$5.36
TSLA
$347.72
+4.1%
+$13.65
CRISPR Therapeutics (NASDAQ: CRSP)
$35.65
(-4.2%)
-$1.57
Price as of May 14, 2025, 3:58 p.m. ET
CRISPR Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CRISPR Therapeutics Company Info
CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.
News & Analysis
The Fool has written over 400 articles on CRISPR Therapeutics.
Featured Article
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?
David Jagielski | May 14, 2025
Featured Article
2 Biotech Stocks That Are Screaming Buys in May
Adria Cimino | May 13, 2025
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
Justin Pope | May 12, 2025
The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.
3 Magnificent Stocks That Could Double or More by 2030
Keith Speights, David Jagielski, and Prosper Junior Bakiny | Apr 12, 2025
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Adria Cimino | Apr 11, 2025
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
Prosper Junior Bakiny | Apr 7, 2025
2 Beaten-Down Stocks to Buy on the Dip
Prosper Junior Bakiny | Mar 22, 2025
Investing in Gene-Editing Stocks
Keith Speights | Mar 20, 2025
Valuation
Podcast Episodes
"The Era of the Gene-Edited Human Is Here"
An investor's look.
Chris Hill | Sep 19, 2022
Breaking Down CRISPR Technology
What investors need to know.
Karl Thiel | Sep 28, 2021
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Todd Campbell | Nov 22, 2019
Did China’s “Designer Babies” Just Open Pandora’s Box?
What will this mean for healthcare and for the future of society?
Motley Fool Staff | Dec 21, 2018
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.